Historical copies of the FDA Orange Book (formally known as Approved Drug Products with Therapeutic Equivalence Evaluations) are potent tools for scholarly research and for litigation support, but until now there has been no central source to get the complete set of archives.
In response to client requests, DrugPatentWatch issued Freedom-of-Information requests to the Food and Drug Administration and also obtained copies of the Orange Book from libraries around the world. The team at DrugPatentWatch is proud to make this resource freely available.
A comprehensive business intelligence tool
In addition to the comprehensive downloadable Orange Book library, DrugPatentWatch also extends the Orange Book with its dynamic platform of international business intelligence on biologic and small-molecule drugs. The business intelligence platform is revised daily and enables complex searches, email updates, and information in litigation, drug prices, and more.
The DrugPatentWatch database builds on the Orange Book by incorporating deep data on US and Global Patents, and broad details such as abandoned and pending patent applications, drug formulation, manufacturers and suppliers, tentative approvals, clinical trials and more. For more details see the DrugPatentWatch homepage and flexible subscription options